ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,066.96
-3.17%
S&P 500
5,509.01
0.62%
Dow Jones
39,331.85
0.41%
US Dollar vs Yen
161.925
0.26%
Brent Oil
86.145
-0.35%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Propanc Biopharma Inc (PK) (PPCBD)

  7. Propanc Biopharma Inc (PK) (PPCBD) ニュース

PPCBD

Propanc Biopharma (PK) (PPCBD)

Propanc Biopharma Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:PPCBD
日付受信時刻ニュースソース見出しコード企業名
2024/07/0302 : 29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/06/2121 : 59Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/06/1319 : 10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
2024/06/1219 : 01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/06/0519 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/05/1619 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/05/1605 : 38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
2024/04/2301 : 12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/04/1105 : 20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/03/1204 : 15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2024/02/2104 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
2024/02/1504 : 47Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/12/1605 : 57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/12/0806 : 18Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/11/1505 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
2023/11/0405 : 05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/10/3105 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/10/2705 : 42Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/10/2705 : 07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/10/1313 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/10/0706 : 26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
2023/09/2905 : 16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:PPCBDPropanc Biopharma Inc (PK)
2023/09/0105 : 08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/09/0105 : 06Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/3105 : 05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/2919 : 04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/2405 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/2206 : 25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/2206 : 25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
2023/08/1705 : 39Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
 Showing the most relevant articles for your search:USOTC:PPCBD

最近閲覧した銘柄

BIT
P1SP45
BNP Paribas Issuance
UNSW3
PRICEETH
PriceCoin
BIT
UC6FVW
Unicredit Bank
BIT
STTE5S
Societe Generale Effekten
BIT
P1Y6N3
NLBNPIT1Y6N3 20240920 55
BIT
UC6Z5M
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有